bioRxiv Science⌕ Search

Biology subjects

Nasim, A.

Publications and source records attributed to Nasim, A..

2 recordsLinked to original sources

EEG-decodability of facial expressions and their stereoscopic depth cues in immersive virtual reality

Face perception typically occurs in three-dimensional space, where stereoscopic depth cues enrich the perception of facial features. Yet, most neurophysiological research on face processing relies on two-dimensional displays, potentially overlooking the role of stereoscopic depth information. Here, we combine immersive virtual reality (VR), electroencephalography (EEG), and eye tracking to examine the neural representation of faces under controlled manipulations of stereoscopic depth. Thirty-four participants viewed computer-generated faces with neutral, happy, angry, and surprised expressions in frontal view under monoscopic and stereoscopic viewing conditions. Using time-resolved multivariate decoding, we show that EEG signals in immersive VR conditions can reliably differentiate facial expressions. Stereoscopic depth cues elicited a distinct and decodable neural signature, confirming the sensitivity of our approach to depth-related processing. Yet, expression decoding remained robust across depth conditions, indicating that under controlled frontal viewing, the neural representation of behaviorally distinguishable facial expressions is invariant to binocular depth cues. Eye tracking showed that expression-related gaze patterns contained comparable information but did not account for neural representations, while depth information was absent in gaze patterns--consistent with dissociable representational processes. Our findings demonstrate the feasibility of EEG-based neural decoding in fully immersive VR as a tool for investigating face perception in naturalistic settings and provide new evidence for the stability of expression representations across depth variations in three-dimensional viewing conditions.

neuroscience↗

A spatially resolved mechanistic growth law for cancer drug development.

Mathematical models used in pre-clinical drug discovery tend to be empirical growth laws. Such models are well suited to fitting the data available, mostly longitudinal studies of tumour volume, however, they typically have little connection with the underlying physiological processes. This lack of a mechanistic underpinning restricts their flexibility and inhibits their direct translation across studies including from animal to human. Here we present a mathematical model describing tumour growth for the evaluation of single agent cytotoxic compounds that is based on mechanistic principles. The model can predict spatial distributions of cell subpopulations and account for spatial drug distribution effects within tumours. Importantly, we demonstrate the model can be reduced to a growth law similar in form to the ones currently implemented in pharmaceutical drug development for pre-clinical trials so that it can integrated into the current workflow. We validate this approach for both cell-derived xenograft (CDX) and patient-derived xenograft (PDX) data. This shows that our theoretical model fits as well as the best performing and most widely used models. However, in addition the model is also able to accurately predict the observed growing fraction of tumours. Our work opens up current pre-clinical modelling studies to also incorporating spatially resolved and multi-modal data without significant added complexity and creates the opportunity to improve translation and tumour response predictions.

pharmacology and toxicology↗